Institutional
Avidity Partners Management LP
CIK 0001791827
$441.9M
Reported AUM
46
Positions
Q1 2026
Period
2026-05-13
Filed
The Brief · Avidity Partners Management LP · Q1 2026
AI · grounded in 13F
Avidity Partners Management LP closed its position in CGON, reducing exposure by $61.1M. The fund established new positions in AKTS and VIR, with investments of $8.8M and $6.3M respectively. Additionally, the fund increased its holdings in PVLA by 262.7% and ELVN by 185.1%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DNTH | DIANTHUS THERAPEUTICS INC | $80.51 | -4.30% | 327.11% | -29.33% | $184.7M | 41.81% | — | HELD |
| 2 | ORKA | ORUKA THERAPEUTICS INC | $60.14 | -3.44% | 378.06% | 194.89% | $52.0M | 11.77% | +100,000 | +15.1% |
| 3 | JBIO | JADE BIOSCIENCES INC | $16.94 | -4.51% | 135.61% | -96.13% | $34.2M | 7.73% | — | HELD |
| 4 | CATX | PERSPECTIVE THERAPEUTICS INC | $2.96 | -2.15% | -8.73% | -56.09% | $23.6M | 5.34% | +2,839,266 | +88.4% |
| 5 | ELVN | ENLIVEN THERAPEUTICS INC | $33.97 | -2.13% | 67.36% | 60.99% | $16.5M | 3.73% | +259,700 | +185.1% |
| 6 | CNTX | CONTEXT THERAPEUTICS INC | $1.73 | -1.43% | 163.55% | -74.56% | $11.8M | 2.67% | −506,588 | −9.2% |
| 7 | RGEN | REPLIGEN CORP | $124.30 | 1.63% | -4.67% | -50.22% | $9.2M | 2.08% | +27,500 | +54.7% |
| 8 | PVLA | PALVELLA THERAPEUTICS INC NE | $109.39 | 0.66% | 327.83% | -60.97% | $9.0M | 2.03% | +50,700 | +262.7% |
| 9 | AKTS | AKTIS ONCOLOGY INC | $18.87 | -5.13% | -15.76% | -6.26% | $8.8M | 1.99% | +468,566 | NEW |
| 10 | MDT | MEDTRONIC PLC | $81.67 | -0.32% | -3.63% | -27.91% | $8.1M | 1.83% | −7,600 | −7.1% |
| 11 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $34.19 | -0.70% | 92.40% | 254.30% | $7.0M | 1.59% | −217,300 | −52.1% |
| 12 | VTLUSD | IMMUNIC INC | — | — | — | — | $6.4M | 1.46% | −4,029,470 | −85.7% |
| 13 | VIR | VIR BIOTECHNOLOGY INC | $8.59 | -0.69% | 58.72% | -75.74% | $6.3M | 1.43% | +619,300 | NEW |
| 14 | DXCM | DEXCOM INC | $72.86 | 0.37% | -15.93% | -43.47% | $6.0M | 1.35% | +100,000 | NEW |
| 15 | HUM | HUMANA INC | $350.08 | 0.08% | 54.14% | -13.78% | $5.9M | 1.34% | +25,000 | NEW |
| 16 | EHC | ENCOMPASS HEALTH CORP | $102.19 | -1.75% | -13.85% | 64.86% | $4.2M | 0.95% | +10,400 | +32.9% |
| 17 | KPTI | KARYOPHARM THERAPEUTICS INC | $9.08 | 0.11% | 102.23% | -92.73% | $3.9M | 0.87% | +329,175 | +244.6% |
| 18 | TEM | TEMPUS AI INC | $47.30 | 1.87% | -25.20% | 7.28% | $3.6M | 0.82% | +65,000 | NEW |
| 19 | TENX | TENAX THERAPEUTICS INC | $10.73 | -3.25% | 77.06% | -99.61% | $3.5M | 0.79% | +265,934 | NEW |
| 20 | BSX | BOSTON SCIENTIFIC CORP | $48.55 | -0.61% | -52.44% | 6.47% | $3.5M | 0.78% | −54,500 | −47.6% |
| 21 | MSLE | SATELLOS BIOSCIENCE INC | $5.62 | -6.49% | 21.85% | -67.98% | $3.1M | 0.70% | +387,769 | NEW |
| 22 | PHAT | PHATHOM PHARMACEUTICALS INC | $10.06 | -0.69% | 13.57% | -68.44% | $2.8M | 0.63% | +43,314 | +21.0% |
| 23 | GILD | GILEAD SCIENCES INC | $129.16 | -0.02% | 17.90% | 125.52% | $2.6M | 0.59% | +20,000 | NEW |
| 24 | GPCR | STRUCTURE THERAPEUTICS INC | $37.58 | -3.79% | 77.85% | 57.97% | $2.0M | 0.45% | +48,000 | NEW |
| 25 | SCYX | SCYNEXIS INC | $4.64 | -1.38% | -35.87% | -91.55% | $1.9M | 0.44% | — | HELD |
| 26 | ICLR | ICON PLC | $149.45 | -2.19% | 7.43% | -38.57% | $1.9M | 0.43% | −17,100 | −51.7% |
| 27 | NTRA | NATERA INC | $215.31 | -3.06% | 31.48% | 88.01% | $1.9M | 0.42% | −2,800 | −23.7% |
| 28 | CRVS | CORVUS PHARMACEUTICALS INC | $11.23 | 0.99% | 184.40% | 432.06% | $1.7M | 0.40% | +115,000 | NEW |
| 29 | PODD | INSULET CORP | $152.64 | -0.38% | -50.85% | -45.22% | $1.7M | 0.39% | +10,000 | NEW |
| 30 | CRL | CHARLES RIV LABS INTL INC | $181.34 | -2.40% | 25.32% | -55.44% | $1.7M | 0.38% | +10,000 | NEW |
| 31 | CORT | CORCEPT THERAPEUTICS INC | $73.99 | 1.89% | — | — | $1.4M | 0.32% | +8,000 | +36.4% |
| 32 | HIMS | HIMS & HERS HEALTH INC | $26.26 | 0.29% | — | — | $1.4M | 0.31% | +50,000 | NEW |
| 33 | GMAB | GENMAB A/S | $24.72 | -1.71% | — | — | $1.3M | 0.30% | −42,000 | −45.7% |
| 34 | PTON | PELOTON INTERACTIVE INC | $5.72 | -0.78% | — | — | $1.1M | 0.25% | +200,000 | NEW |
| 35 | NTLA | INTELLIA THERAPEUTICS INC | $13.62 | 0.63% | — | — | $1.0M | 0.23% | +75,000 | NEW |
| 36 | ODD | ODDITY TECH LTD | $9.81 | -2.58% | — | — | $1.0M | 0.23% | +70,000 | NEW |
| 37 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $9.51 | -1.35% | — | — | $923K | 0.21% | +150,000 | NEW |
| 38 | ABT | ABBOTT LABORATORIES | $91.07 | 0.32% | — | — | $908K | 0.21% | +10,000 | NEW |
| 39 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $18.07 | 0.92% | — | — | $819K | 0.19% | +50,000 | NEW |
| 40 | BBIO | BRIDGEBIO PHARMA INC | $66.96 | -0.97% | — | — | $711K | 0.16% | +10,000 | NEW |
| 41 | ABUS | ARBUTUS BIOPHARMA CORP | $4.24 | -0.12% | — | — | $525K | 0.12% | +125,000 | NEW |
| 42 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $7.91 | 1.28% | — | — | $369K | 0.08% | +43,853 | NEW |
| 43 | LEGN | LEGEND BIOTECH CORP | $29.96 | -8.15% | — | — | $353K | 0.08% | +15,000 | NEW |
| 44 | ACAD | ACADIA PHARMACEUTICALS INC | $21.56 | -0.74% | — | — | $291K | 0.07% | −93,933 | −87.9% |
| 45 | SVRA | SAVARA INC | $5.09 | -3.96% | — | — | $262K | 0.06% | +50,000 | NEW |
| 46 | TRVI | TREVI THERAPEUTICS INC | $13.33 | -4.31% | — | — | $92K | 0.02% | +6,660 | NEW |
| 47 | CGON | CG ONCOLOGY INC | $53.72 | -4.23% | — | — | — | — | −1,472,699 | EXITED |
| 48 | ALNY | ALNYLAM PHARMACEUTICALS INC | $303.05 | -0.19% | — | — | — | — | −21,000 | EXITED |
| 49 | MCK | MCKESSON CORP | $775.66 | 2.47% | — | — | — | — | −9,520 | EXITED |
| 50 | A | AGILENT TECHNOLOGIES INC | $135.41 | -0.02% | — | — | — | — | −41,500 | EXITED |
| 51 | PFE | PFIZER INC | $26.04 | 1.36% | — | — | — | — | −203,600 | EXITED |
| 52 | CNC | CENTENE CORP DEL | $62.33 | -0.59% | — | — | — | — | −119,400 | EXITED |
| 53 | KVUE | KENVUE INC | $17.71 | 4.92% | — | — | — | — | −232,800 | EXITED |
| 54 | DHR | DANAHER CORPORATION | $184.30 | -1.25% | — | — | — | — | −17,000 | EXITED |
| 55 | TMO | THERMO FISHER SCIENTIFIC INC | $472.80 | -1.91% | — | — | — | — | −6,700 | EXITED |
| 56 | NVO | NOVO-NORDISK A S | $42.96 | -1.81% | — | — | — | — | −67,300 | EXITED |
| 57 | CI | THE CIGNA GROUP | $289.48 | 3.14% | — | — | — | — | −11,600 | EXITED |
| 58 | COR | CENCORA INC | $275.04 | 1.75% | — | — | — | — | −9,400 | EXITED |
| 59 | INSM | INSMED INC | $92.67 | -1.65% | — | — | — | — | −17,700 | EXITED |
| 60 | WAT | WATERS CORP | $365.36 | -2.95% | — | — | — | — | −8,100 | EXITED |
| 61 | ACHC | ACADIA HEALTHCARE COMPANY IN | $24.48 | -2.90% | — | — | — | — | −169,000 | EXITED |
| 62 | ITGR | INTEGER HLDGS CORP | $93.46 | 1.61% | — | — | — | — | −29,800 | EXITED |
| 63 | HQY | HEALTHEQUITY INC | $88.67 | 3.07% | — | — | — | — | −16,900 | EXITED |
| 64 | IQV | IQVIA HLDGS INC | $184.41 | 0.52% | — | — | — | — | −4,400 | EXITED |
Source: SEC EDGAR · accession 0001791827-26-000003. 13F discloses long positions only — shorts, foreign equities, and options are excluded.